AI MARKET SCANNING

Pmv Pharmaceuticals Inc

📅 Next Catalyst: Nov 16, 2026 (☀️ Open) 🏛️ NASDAQ 📁 Health Technology 🏭 Biotechnology
AVG HISTORICAL GAP +0.72%
MAX GAP RECORD +6.54%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $PMVP
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Nov 16, 2026 Earnings Release 2026-11-16 (BEFORE OPEN (07:00)) 🔮 UPCOMING 🔒
Aug 13, 2026 Earnings Release 2026-08-13 (BEFORE OPEN (08:00))
+2.38%
May 12, 2026 Earnings Release 2026-05-12 (BEFORE OPEN)
+3.60%
Mar 06, 2026 Earnings Release 2026-03-06 (BEFORE OPEN)
+6.54%
Nov 12, 2025 Earnings Release 2025-11-12 (BEFORE OPEN)
+1.50%
Aug 07, 2025 Earnings Release 2025-08-07 (BEFORE OPEN)
-1.97%
May 09, 2025 Earnings Release 2025-05-09 (BEFORE OPEN)
-3.85%
Mar 03, 2025 Earnings Release 2025-03-03 (BEFORE OPEN)
-0.73%

VOLATILITY & GAP BIAS

AVG GAP MOVE 2.2%
Bullish Gaps (7)
Bearish Gaps (3)
Neutral / Flat (4)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $PMVP

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

PMV Pharmaceuticals, Inc. is a precision oncology company, which engages in the discovery and development of small molecule, tumor-agnostic therapies targeting p53. The company was founded by Arnold J. Levine, David Henry Mac, and Thomas E. Shenk in March 2013 and is headquartered in Princeton, NJ.

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗